Table 3 Anti-HBc status among studied patients.

Age (years)

t Test

X^- ± SD

43.4 ± 9.1

41.6 ± 9.2

0.79

0.43

Range

28-59

19-59

Sex

No.

%

No.

%

X ²

M

16

88.9

109

79.6

0.39

0.53

F

2

11.1

28

20.4

Activity

No.

%

No.

%

X ²

1

2

22.15

50

36.5

2

12

66.7

59

43.1

5.02

0.08

3

4

22.15

28

20.4

Fibrosis

No.

%

No.

%

X ²

1

4

22.2

49

35.7

2

6

33.3

56

41.0

5.55

0.13

3

8

44.4

28

20.4

4

0

0.0

4

2.9

Basal HCV Viral Load (IU × 10⁵)

t Test

X^- ± SD

9.43 ± 9.9

3.1 ± 4.5

4.66

< 0.001*

Range × 10⁵

0.62-22.3

0.001-21

Basal ALT(× ULN)

No.

%

No.

%

X ²

≤ 2

14

77.8

102

74.5

0.001

0.98

> 2

4

22.2

35

25.5

Basal AST (× ULN)

No.

%

No.

%

X ²

≤ 2

16

88.9

108

78.8

0.48

0.49

> 2

2

11.1

29

21.2

HBV DNA

No.

%

No.

%

X ²

Positive

2

11.1

4

2.9

1.09

0.29

Negative

16

88.9

133

97.1

Response Rate

No.

%

No.

%

X ²

Responder

4

22.2

66

48.2

5.58

0.018*

Non-responder

14

77.8

71

51.8

Anti-HBs

No.

%

No.

%

X ²

Positive

4

22.2

14

10.2

1.22

0.26

Negative

14

77.8

123

89.8